1 citations
,
October 2022 in “Asian journal of medical sciences” This study found trichoscopy to be a highly sensitive, non-invasive method for diagnosing tinea capitis in children, which could be valuable in resource-limited settings lacking mycological culture facilities.
1 citations
,
January 2022 in “Open Access Macedonian Journal of Medical Sciences” This case report highlights that healthcare providers should consider the possibility of systemic lupus erythematosus in children with immune thrombocytopenia.
1 citations
,
December 2021 in “Revista Extensão & Cidadania/Revista Extensão e Cidadania” This study identified recurrent dry cough, wheezing, and respiratory discomfort as key symptoms valued in early asthma diagnosis among children aged 5 to 12.
1 citations
,
December 2018 in “Indian journal of paediatric dermatology” This study found that children with alopecia areata had significantly lower serum vitamin D levels than healthy controls.
1 citations
,
September 2015 in “Clinics in Dermatology” This article offers a question-by-question guide to assist clinicians in diagnosing hair shaft disorders, presenting no new clinical results.
This study observed that nearly 70% of children with treatment-resistant alopecia areata had nail involvement, predominantly pitting, which was significantly linked to longer disease duration but not the severity of scalp hair loss.
This study observed that nearly 70% of children with treatment-resistant alopecia areata had nail involvement, and while this was associated with longer disease duration, it did not correlate with the severity of scalp hair loss.
July 2026 in “Journal of the American Academy of Dermatology” Severe alopecia areata in children greatly affects their mental and social well-being, and addressing these challenges is crucial.
In this case report, an 11-year-old girl with dissecting cellulitis of the scalp showed an excellent response to oral isotretinoin after other treatments failed, highlighting the treatment challenges and need for awareness in managing this rare condition.
May 2026 in “European Burn Journal” This systematic review concluded that the scalp can be a safe and effective donor site for split-thickness skin grafts in pediatric burn patients, with evidence indicating good scar quality and manageable complications, though a rigorous technique is essential to minimize risks.
February 2026 in “Reports — Medical Cases Images and Videos” This retrospective case series reported that pediatric patients with alopecia totalis and subtotalis experienced significant hair regrowth after treatment with the JAK inhibitor upadacitinib, with mild acne as the most common side effect; however, larger studies are needed to establish its efficacy and safety conclusively.
February 2026 in “Cureus” This case report suggests that crisaborole may be an effective alternative treatment for alopecia areata in pediatric patients, showing significant hair regrowth after two weeks in a 10-year-old girl.
January 2026 in “Ciencia Latina Revista Científica Multidisciplinar” This study reports on a 14-year-old male with refractory diffuse alopecia areata who achieved full hair density restoration after three monthly sessions of microneedling combined with triamcinolone, dutasteride, and synthetic exosome treatment, highlighting exosomes' potential for enhancing traditional therapies in autoimmune hair loss cases.
January 2026 in “Saudi Journal of Internal Medicine” This narrative review suggests that while corticosteroids and Janus kinase inhibitors may be effective for treating ophiasis-pattern alopecia areata in both adults and children, the limited age-specific evidence underscores the need for further research to confirm their efficacy and safety across age groups.
December 2025 in “Frontiers in Medicine” This case report presents the first instance of a pediatric alopecia areata patient switching from baricitinib to ritlecitinib, demonstrating favorable clinical outcomes, suggesting a potential new treatment pathway for children with severe cases of this condition.
November 2025 in “Journal of Investigative Dermatology” This case series observed that five Black pediatric patients with moderate to severe alopecia areata showed significant hair regrowth and minimal disease activity after treatment with topical JAK inhibitors, vitamin D supplementation, and antihistamines, with additional therapies in some cases.
August 2025 in “Kuban Scientific Medical Bulletin” In this study, researchers identified immune differences in children with alopecia areata, finding that cytokine profiles vary based on the presence of atopic diseases; notably, patients with atopy showed a heightened T helper 2 response, potentially influencing cytokine expression and disease severity.
August 2025 in “Archives of Dermatological Research” This systematic review and meta-analysis suggest that oral minoxidil may be a safer and more effective option for children with hair disorders and refractory hypertension, though further large-scale trials are needed.
This case study reports that a pediatric patient with recalcitrant alopecia areata was treated using a 308 nm excimer lamp and topical tofacitinib 2% gel.
May 2025 in “Medical Journal of Dr D Y Patil Vidyapeeth” This report presents a unique case of folliculitis decalvans in two young sisters managed with low-dose isotretinoin and erythromycin, without specifying the treatment's success.
May 2025 in “International Journal of Trichology” In this case report, a 7-year-old boy with alopecia totalis experienced significant hair regrowth after adding topical tofacitinib and mometasone to his treatment regimen, suggesting potential benefits of topical Janus kinase inhibitors for pediatric patients with this condition.
April 2025 in “Journal of the American Academy of Dermatology” The study has limitations, and future research should use better methods to improve treatment for children with hair loss.
April 2025 in “International Journal of Homoeopathic Sciences” In this case report, a 7-year-old boy with patchy hair loss due to alopecia areata showed significant hair regrowth and improvement in psychological well-being after a holistic homeopathic treatment identified emotional distress as a root cause.
January 2025 in “Indian Journal of Paediatric Dermatology” This study found no significant difference in serum Vitamin D levels between children with alopecia areata and healthy controls, nor was there any correlation between Vitamin D levels and the severity, duration, or pattern of the condition, or nail changes.
December 2024 in “International Journal For Multidisciplinary Research” This study found that monotherapy and topical medications are primarily used to treat pediatric skin diseases, with a variety of drugs prescribed indicating the complexity of these conditions.
In this retrospective study of 133 pediatric patients, topical minoxidil was generally well tolerated for managing androgenetic alopecia, but close monitoring and adherence to treatment, accounting for hormonal and concurrent conditions, were emphasized for effective care.
August 2024 in “Jordan Medical Journal” In this study conducted at a pediatric clinic in southern Jordan, researchers found that picky eating is linked to lower serum zinc levels, lower weight for age, and deficiencies in hemoglobin and vitamin D, indicating a broader range of nutritional deficiencies than just zinc deficiency.
March 2024 in “Journal of functional biomaterials” This study demonstrated that a strain of lactic acid bacteria from kimchi, identified as Pediococcus inopinatus, showed antibacterial activity against certain oral pathogens and effectively bleached stained artificial teeth and inhibited biofilm formation, offering potential for addressing teeth discoloration and halitosis.
January 2024 in “Skin Research and Technology” This case report found that oral tofacitinib treatment resulted in more than 90% hair regrowth in a 6-year-old with severe alopecia areata, with no relapse after dose reduction.
November 2023 in “Children” In this study, valproic acid, levetiracetam, and phenytoin were the main anti-seizure medications associated with adverse drug reactions in pediatric epilepsy patients, with younger children and those on polytherapy at higher risk.